Sector: Healthcare âĸ All Insider Transactions
đ Last update: 11/17/2026 at 14:20 UTCHCA stock price â last 6 months
Ⲡ= insider buy (0), âŧ = insider sell (10)
Data from Yahoo Finance, 15-min delay. Last update: 16/11/2026 (market close).
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 11/10/2026 | Rossitto Erica | SVP & Chief Nurse Executive | Sale | 3,500 | $505.81 | $1.8M |
| 11/06/2026 | Rossitto Erica | SVP & Chief Nurse Executive | Exercise | 8,080 | $81.96 | $0.7M |
| 11/06/2026 | Rossitto Erica | SVP & Chief Nurse Executive | Exercise | 5,040 | $101.16 | $0.5M |
| 11/06/2026 | Rossitto Erica | SVP & Chief Nurse Executive | Tax | 6,601 | $494.99 | $3.3M |
| 11/06/2026 | Rossitto Erica | SVP & Chief Nurse Executive | Exercise | 8,080 | â | â |
| 11/06/2026 | Rossitto Erica | SVP & Chief Nurse Executive | Exercise | 5,040 | â | â |
| 11/06/2026 | Foster Jon M | EVP and COO | Sale | 890 | $498.97 | $0.4M |
| 11/06/2026 | Foster Jon M | EVP and COO | Sale | 1,684 | $498.00 | $0.8M |
| 11/06/2026 | Foster Jon M | EVP and COO | Sale | 1,066 | $496.92 | $0.5M |
| 11/06/2026 | Foster Jon M | EVP and COO | Sale | 2,692 | $495.85 | $1.3M |
| 11/06/2026 | Foster Jon M | EVP and COO | Sale | 7,595 | $494.91 | $3.8M |
| 11/06/2026 | Foster Jon M | EVP and COO | Sale | 6,302 | $493.58 | $3.1M |
| 11/06/2026 | Foster Jon M | EVP and COO | Sale | 1,484 | $491.98 | $0.7M |
| 11/04/2026 | Elcan Patricia F | 10% Owner | Disposition | 886,871 | $503.52 | $446.6M |
| 11/04/2026 | Elcan Patricia F | 10% Owner | J | 886,871 | $503.52 | $446.6M |
| 11/04/2026 | FRIST THOMAS F III | Director | Disposition | 555,500 | $503.52 | $279.7M |
| 11/04/2026 | FRIST THOMAS F III | Director | J | 555,500 | $503.52 | $279.7M |
| 11/04/2026 | Schlosser Michael J | EVP and Chief Clinical Officer | Sale | 1,200 | $494.65 | $0.6M |
| 11/04/2026 | Foster Jon M | EVP and COO | Sale | 10,000 | $514.07 | $5.1M |
| 11/04/2026 | Foster Jon M | EVP and COO | Exercise | 35,880 | $145.24 | $5.2M |
| 11/04/2026 | Foster Jon M | EVP and COO | Tax | 20,309 | $510.70 | $10.4M |
| 11/04/2026 | Foster Jon M | EVP and COO | Disposition | 16,142 | $503.52 | $8.1M |
| 11/04/2026 | Foster Jon M | EVP and COO | Exercise | 35,880 | â | â |
| 11/02/2026 | Marks Mike A | EVP and CFO | Disposition | 1,042 | $469.40 | $0.5M |
| 11/02/2026 | Marks Mike A | EVP and CFO | Gift | 1,042 | â | â |
| 10/30/2026 | Marks Mike A | EVP and CFO | Exercise | 4,585 | $81.96 | $0.4M |
| 10/30/2026 | Marks Mike A | EVP and CFO | Tax | 2,287 | $473.19 | $1.1M |
| 10/30/2026 | Marks Mike A | EVP and CFO | Exercise | 4,585 | â | â |
| 10/29/2026 | Schlosser Michael J | EVP and Chief Clinical Officer | Exercise | 3,030 | $81.96 | $0.2M |
| 10/29/2026 | Schlosser Michael J | EVP and Chief Clinical Officer | Exercise | 1,898 | $82.85 | $0.2M |
| 10/29/2026 | Schlosser Michael J | EVP and Chief Clinical Officer | Tax | 2,455 | $478.08 | $1.2M |
| 10/29/2026 | Schlosser Michael J | EVP and Chief Clinical Officer | Exercise | 3,030 | â | â |
| 10/29/2026 | Schlosser Michael J | EVP and Chief Clinical Officer | Exercise | 1,898 | â | â |
| 10/29/2026 | Schlosser Michael J | EVP and Chief Clinical Officer | Award | 2,797 | â | â |
| 08/26/2026 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | Disposition | 7,769 | $429.00 | $3.3M |
| Insider | Role | Shares Held | Last Transaction |
|---|---|---|---|
| Elcan Patricia F | 10% Owner | 32.3M | 11/04/2026 |
| FRIST THOMAS F III | Director | 32.3M | 11/04/2026 |
| Foster Jon M | EVP and COO | 30,823 | 11/06/2026 |
| Marks Mike A | EVP and CFO | 25,458 | 11/02/2026 |
| Rossitto Erica | SVP & Chief Nurse Executive | 13,426 | 11/10/2026 |
| Schlosser Michael J | EVP and Chief Clinical Officer | 1,443 | 11/04/2026 |
Form 144 is filed BEFORE the actual sale. It is an important leading indicator.
| Filing Date | Type | SEC Link |
|---|---|---|
| 11/10/2026 | 144 | View Filing â |
| 11/04/2026 | 144 | View Filing â |
| 11/04/2026 | 144 | View Filing â |
| 10/29/2026 | 144 | View Filing â |
Recent financial data from SEC filings (XBRL) to contextualize insider activity.
Legal insider trading occurs when executives, directors, and major shareholders (>10%) of a public company buy or sell shares of their own company and report it to the SEC via Form 4.
Open market purchases (P) â the strongest signal. The insider uses their own money to buy shares.
All data on this page comes directly from public SEC filings.
đ View all Form 4 filings on SEC EDGAR HCA âOther Healthcare stocks with monitored insider activity:
Stocks with the highest number of recent insider transactions: